XYRAVIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 Aug 2018)
What this means for you
This application is over — abandoned 06 Aug 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86846265
- Mark type
- Stylized text
- Filed
- 11 Dec 2015
- Published for opposition
- 26 Jul 2016
- Abandoned
- 06 Aug 2018
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, antibiotics; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of, the central nervous system, sleep disorders, cognitive disorders, fibromyalgia, insomnia, narcolepsy, and neurological or psychiatric diseases or disorders
Owner
- Tetraphase Pharmaceuticals, Inc., Watertown, MA, US
- Tetraphase Pharmaceuticals, Inc., Watertown, MA, US
Prosecution history
- 06 Aug 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 06 Aug 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Aug 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2017 — SOU EXTENSION 1 GRANTED
- 01 Aug 2017 — SOU EXTENSION 1 FILED
- 01 Aug 2017 — SOU TEAS EXTENSION RECEIVED
- 04 Jul 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 May 2017 — TTAB RELEASE CASE TO TRADEMARKS
- 24 May 2017 — OPPOSITION TERMINATED NO. 999999
- 24 May 2017 — OPPOSITION DISMISSED NO. 999999
- 23 Nov 2016 — OPPOSITION INSTITUTED NO. 999999
- 25 Aug 2016 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 26 Jul 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jul 2016 — PUBLISHED FOR OPPOSITION
- 06 Jul 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED